⌘K

Login Start Free

Home/Filings/4/0001225471-25-000006

4//SEC Filing

SING GEORGE L 4

Accession 0001225471-25-000006

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Dec 30, 7:00 PM ET

Accepted

Dec 31, 5:05 PM ET

Size

10.1 KB

Accession

0001225471-25-000006

Insider Transaction Report

Form 4

Period: 2025-12-30

REGENERON PHARMACEUTICALS, INC.REGN

Director

Transactions

Exercise/Conversion
Common Stock
2025-12-30$520.01/sh+9,212$4,790,332→ 37,040 total
Tax Payment
Common Stock
2025-12-30$774.03/sh−6,188$4,789,698→ 30,852 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-12-30−9,212→ 0 total
Exercise: $520.01Exp: 2026-01-04→ Common Stock (9,212 underlying)

Holdings

Common Stock
(indirect: By Spouse)
750
Common Stock
(indirect: By Spouse)
400
Common Stock
(indirect: By Trust)
1,000

Footnotes (1)

[F1]The stock option vested in three equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0001225471

Filing Metadata

Form type: 4
Filed: Dec 30, 7:00 PM ET
Accepted: Dec 31, 5:05 PM ET
Size: 10.1 KB

View on SEC.gov